Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Abuscreen OnLine II for Opiates 300/2000 Reagent is an in vitro diagnostic test for the qualitative (at 300 and 2000 ng/mL cutoff) and semi-quantitative (at 2000 ng/mL cutoff) detection of morphine and its metabolites in human urine.

    The Abuscreen ONLINE Opiates Calibration Pack is an in vitro diagnostic device designed for the calibration of the Roche reagent assays for opiates.

    The Roche Abuscreen ONLINE Opiates Control Pack is an assayed quality control sample for use with the Roche assays for opiates.

    Device Description

    The Abuscreen OnLine II for Opiates 300/2000 Reagent is an in vitro diagnostic test for the qualitative (at 300 and 2000 ug/mL cutoff) and serni-quantitative (at 2000 ng/mL cutoff) detection of morphine and its metabolites in human urine.

    The Abuscreen OnLine Opiates Calibration Pack is an in vitro diagnostic device designed for the calibration of the Roche reagent assays for opiates.

    The Roche Abuscreen ONLINE Opiates Control Pack is an assayed quality control sample for use with the Roche assays for opiates.

    AI/ML Overview

    The Abuscreen OnLine II for Opiates 300/2000 Reagent is an in vitro diagnostic test designed for the qualitative and semi-quantitative detection of morphine and its metabolites in human urine. The following describes its acceptance criteria and the study that demonstrates its performance.

    1. Table of Acceptance Criteria and Reported Device Performance

    Performance CharacteristicAcceptance Criteria (Predicate Device)Reported Device Performance (Abuscreen OnLine II Opiates Reagent)
    300 ng/mL Qualitative Application
    Assay RangeUp to 600 ng/mLUp to 2000 ng/mL
    Precision (Negative Reading)>95% confidence at 80% cutoff>95% confidence at 80% cutoff
    Precision (Positive Reading)>95% confidence at 120% cutoff>95% confidence at 120% cutoff
    Accuracy (% Agreement vs. GC/MS)100% (N=49)100% (N=40)
    Sensitivity (Analytical)
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1